A study of the stimulation of human venous prostacyclin synthesis by dipyridamole
- 1 September 1982
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 27 (5) , 563-573
- https://doi.org/10.1016/0049-3848(82)90303-6
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- DIFFERENTIAL INHIBITION BY LOW-DOSE ASPIRIN OF HUMAN VENOUS PROSTACYCLIN SYNTHESIS AND PLATELET THROMBOXANE SYNTHESISThe Lancet, 1981
- Inhibition of Prostacyclin and Platelet Thromboxane A2after Low-Dose AspirinNew England Journal of Medicine, 1981
- DIPYRIDAMOLE: A POTENT STIMULATOR OF PROSTACYCLIN (PGI2) BIOSYNTHESISBritish Journal of Pharmacology, 1980
- STIMULATION OF PROSTACYCLIN BY DIPYRIDAMOLEThe Lancet, 1979
- Mode of action of dipyridamole on human plateletsThrombosis Research, 1979
- DIPYRIDAMOLE AND OTHER PHOSPHODIESTERASE INHIBITORS ACT AS ANTITHROMBOTIC AGENTS BY POTENTIATING ENDOGENOUS PROSTACYCLINThe Lancet, 1978
- Uptake and metabolism of adenosine by pig aortic endothelial and smooth-muscle cells in cultureBiochemical Journal, 1978
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976
- HomocystinemiaNew England Journal of Medicine, 1974
- Aspirin Selectively Inhibits Prostaglandin Production in Human PlateletsNature New Biology, 1971